SAN DIEGO, April 11, 2011 /PRNewswire/ -- ResMed Corp. (NYSE: RMD) today released its new S9 VPAP™ series of bilevel devices. Based on ResMed's latest design and technology platform, the new bilevels ...
A patient's ability to comply with sleep therapy, however, is affected by potential negative side effects, such as noise from the device, nasal dryness/congestion and breathing discomfort. To combat ...
The S9 Elite™ is a whisper quiet, elegant and comfortable therapy system for the treatment of Obstructive Sleep Apnoea (OSA). The S9 Elite provides Continuous Positive Airway Pressure (CPAP) with Easy ...
55% of HME respondents say mask selection is the biggest challenge during remote CPAP setups in a recent survey SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD) has launched ResMed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback